MedPath

Early Vision Screening in High-risk Children

Conditions
Child
Amblyopia
Registration Number
NCT02678468
Lead Sponsor
Far Eastern Memorial Hospital
Brief Summary

To evaluate the effect of early vision screening with automated photorefraction device in high risk children

Detailed Description

Pre-term, low-birth-weight, and development delay are well-known risk factors related to higher incidence of high refractive error and strabismus, which can potentially lead to amblyopia and is regarded as amblyopia risk factors. This project is a cross-sectional controlled study. Our study includes high-risk group and normal group. High-risk group includes children with birth history of pre-term, low-birth-weight and the diagnosis of development delay in FEMH. Normal group enrolled age-matched children without those risk factors. Vision screening by FDA-approved photorefraction device as well as comprehensive ophthalmic exams for definite diagnosis will be performed on the high-risk group and the normal group.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • High risk group: children with gestational age less than 36weeks, birth weight less than 2500g and children diagnosed as develop delay
  • Normal group: children with normal birth history and normal development
Exclusion Criteria
  • Children with known ophthalmic diseases
  • Children with congenital systemic diseases

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
positive predictive value of vision screeningone year

positive predictive value

Secondary Outcome Measures
NameTimeMethod
Odds ratio of having amblyopia risk factorsone year

Odds ratio

Trial Locations

Locations (1)

Far Eastern Memorial Hospital

🇨🇳

New Taipei City, Other, Taiwan

© Copyright 2025. All Rights Reserved by MedPath